The term ‘medicinal product’ in Article 1(2)(b) of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, as amended by Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, must be interpreted as meaning that it does not cover substances or combinations of substances, such as preparations based on herbs and synthetic cannabinoids, which are capable of modifying human physiological functions but whose administration, purely for recreational purposes, is not intended to prevent or cure disease.
Eric, stavit ću te u sve moje predstave!EurLex-2 EurLex-2